| Status | Study |
| Recruiting |
Study Name: Urine, DNA and Clinical Information Collection From Patients With Alport Nephropathy. Condition: Alport Nephropathy Date: 2017-02-23 |
| Recruiting |
Study Name: A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL Condition: Alport Syndrome Date: 2017-01-06 Interventions: Drug: Placebo Oral Capsule Cap |
| Active, not recruiting |
Study Name: Study of Weekly RG-012 Injections in Patients With Alport Syndrome Condition: Alport Syndrome Date: 2016-07-28 Interventions: Drug: RG-012 RG456070 in 0.3% |
| Recruiting |
Study Name: Biomarker for Patient With Alport Disease or Highly Suspected for Alport Disease Condition: Nephritis, Hereditary Alport Syndrome Date: 2015-11-10 |
| Recruiting |
Study Name: European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome Condition: Alport Syndrome Hereditary Kidney Disease Date: 2015-02-26 Interventions: Drug: ACE-inhibitor observatio |
| Recruiting |
Study Name: ATHENA: Natural History of Disease Study in Alport Syndrome Patients Condition: Alport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2 Date: 2014-05-09 |
| Completed |
Study Name: Urinary Biomarkers of the Progression of Alport Kidney Disease Condition: Alport Syndrome Date: 2012-10-08 |
| Active, not recruiting |
Study Name: Multi-center Controlled Clinical Trials in Alport Syndrome-A Feasibility Study Condition: Alport Syndrome Date: 2012-09-20 |
| Terminated |
Study Name: Human Urine Sample Collection for Alport Nephropathy Biomarker Studies Condition: Alport Syndrome Date: 2012-05-17 |
| Recruiting |
Study Name: Efficacy and Safety Study to Delay Renal Failure in Children With Alport Syndrome Condition: Renal Insufficiency, Chronic Date: 2011-12-02 Interventions: Drug: Ramipril Ramipril (Delix |